CD4BS CH505M5 Pr-NP1
- Generic Name
- CD4BS CH505M5 Pr-NP1
A Clinical Trial in Adult Participants Without HIV and in Overall Good Health to Evaluate the Safety and Immunogenicity of CD4BS CH505M5 Pr-NP1 Followed by CH505 TF chTrimer Boost Both Adjuvanted With Either Lipid Nanoparticles (LNPs) or 3M-052-AF + Alum
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2025-03-26
- Target Recruit Count
- 42
- Registration Number
- NCT06267872
- Locations
- 🇺🇸
Alabama CRS (Site ID: 31788), Birmingham, Alabama, United States
🇺🇸The Ponce de Leon Center CRS (Site ID: 5802), Atlanta, Georgia, United States
🇺🇸Vanderbilt Vaccine (VV) CRS (Site ID: 30352), Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath